Phase 1 Study of Terameprocol (EM-1421) in Patients With Leukemia

NCT00664677 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

16

Enrollment

INDUSTRY

Sponsor class

Stopped Funding constraints

Conditions

Leukemias
Acute Myeloid Leukemia (AML)
Acute Lymphocytic Leukemia (ALL)
Adult T Cell Leukemia (ATL)
Chronic Myeloid Leukemia (CML-BP)
Chronic Lymphocytic Leukemia (CLL)
Myelodysplastic Syndrome (MDS)
Chronic Myelomonocytic Leukemia (CMML)

Interventions

DRUG: Terameprocol (EM-1421)

Sponsor

Erimos Pharmaceuticals